Regulation Microglia Activation Mediated Neuroinflammation to Ameliorate Ischemia-reperfusion Injury via STAT5-NF-kappa B Pathway in Ischemic Stroke
Send a publication request
close

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.




- Categories : Ischemic Strokes , Publications

Authors
Z Pu, S Xia, P Shao et al


Lab
Nanjing University, Nanjing, P.R. China

Journal
Brain Sciences

Abstract
Inflammatory reaction after ischemia-reperfusion contributes significantly to prognosis, and microglia activation is the main resource of inflammation in nervous system. STAT5 is proving to be a highly effective anti-inflammatory therapy with great potential, and inhibition of STAT5 has demonstrated significant anti-inflammation and therapeutic effects, but rarely focus on mechanism of neuroinflammation and brain injury from ischemia-reperfusion. It is the first time to found that the anti-inflammation of dauricine is mainly through STAT5-NF-kappa B pathway, might act as a STAT5 inhibitor. Dauricine suppressed the inflammation cytokines Eotaxin, KC, TNF-alpha, IL-1alpha, IL-1beta, IL-6, IL-12beta, IL-17alpha, and also inhibited the microglia activation. STAT5b mutant at Tyr-699 reversed the protective effect of dauricine on oxygen-glucose deprivation-reperfusion injury of neurons, and re activated the suppression of dauricine on P-NF-kappa B of microglia. These results suggest that dauricine might suppress the neuroinflammation and protect the neuron from the injury of post-ischemia reperfusion via mediating the microglia activation through STAT5-NF-kapp B pathway, and as a potential therapeutic target for neuroinflammation, STAT5 needs to be raised concern in ischemic stroke

BIOSEB Instruments Used:
Grip strength test (BIO-GS3)

Related products

Share this content